IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8788
EU - Europa 1395
AF - Africa 350
AS - Asia 253
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 10814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8622
NG - Nigeria 350
FI - Finlandia 335
FR - Francia 163
CA - Canada 162
IT - Italia 159
DE - Germania 154
IE - Irlanda 144
SE - Svezia 120
NL - Olanda 113
BE - Belgio 81
TR - Turchia 80
GB - Regno Unito 79
CN - Cina 55
IL - Israele 47
HK - Hong Kong 18
IR - Iran 13
SG - Singapore 13
IN - India 10
CL - Cile 8
EU - Europa 8
RU - Federazione Russa 8
AT - Austria 6
JP - Giappone 5
AU - Australia 4
BR - Brasile 4
CH - Svizzera 4
ES - Italia 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
EE - Estonia 3
RO - Romania 3
TH - Thailandia 3
UA - Ucraina 3
BD - Bangladesh 2
GR - Grecia 2
NO - Norvegia 2
PL - Polonia 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IS - Islanda 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10814
Salva come PNG Salva come JPEG
Città #
Wilmington 2017
Chandler 1895
San Mateo 779
Ann Arbor 613
Leawood 403
Benin City 350
Helsinki 335
Lawrence 329
Princeton 329
Fairfield 198
Woodbridge 182
Paris 160
Toronto 159
Dublin 144
Boardman 112
Amsterdam 108
Brussels 81
Kocaeli 80
London 74
Milan 68
Seattle 60
San Diego 58
Norwalk 51
Monmouth Junction 44
Beijing 30
Falls Church 30
Houston 16
Redmond 15
Redwood City 14
Hanover 13
Ashburn 12
Cambridge 11
Des Moines 10
Berlin 9
Singapore 8
Terracina 8
Abbiategrasso 7
Andover 7
Falkenstein 6
Zhengzhou 6
Augusta 5
Florence 5
Jacksonville 5
Chengdu 4
Mumbai 4
Sacramento 4
San Jose 4
St Petersburg 4
Vienna 4
Clearwater 3
Frankfurt am Main 3
Hebei 3
Osimo 3
Phoenix 3
Pozzuoli 3
Saint Paul 3
Santa Clara 3
Tallinn 3
Apo 2
Avigliano 2
Bangkok 2
Buffalo 2
Chongqing 2
Guangzhou 2
Gurgaon 2
Hangzhou 2
Issiglio 2
Kwun Hang 2
Las Vegas 2
New York 2
Norfolk 2
Rotterdam 2
Saint Louis 2
Sherbrooke 2
Trento 2
Umeå 2
Valencia 2
Alcamo 1
Ardabil 1
Athens 1
Belgrade 1
Bergamo 1
Bitola 1
Bratislava 1
Böblingen 1
Changchun 1
Chisinau 1
Copenhagen 1
Dalmine 1
Den Haag 1
Ferrara 1
Ferrara di Monte Baldo 1
Freiburg 1
Gerenzano 1
Henderson 1
Il-Madliena 1
Keflavik 1
La Canada Flintridge 1
Leninsk-kuznetskiy 1
Lisbon 1
Totale 8958
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 78
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 67
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 66
11Cl-choline PET/CT in imaging locally advanced prostate cancer 64
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 58
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 55
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 55
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 53
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 53
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 52
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 52
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 51
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 51
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 50
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 50
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 50
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 50
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 50
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 50
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 50
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 49
Evaluation of response: is F-18-FDG PET the answer? 48
C-11-Methionine uptake in secondary brain epilepsy 48
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 47
Radiopharmaceuticals for breast cancer imaging 47
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 47
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 47
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 47
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 47
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 46
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 46
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 45
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 45
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 45
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 45
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 44
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 44
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 43
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 43
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 43
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 43
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 43
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 43
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 43
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 43
EANM procedure guideline for treatment of refractory metastatic bone pain 42
Nuclear medicine procedures in lung cancer 42
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 42
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 42
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 42
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 42
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 42
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 42
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 42
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 41
FDG PET/CT predictive role in follicular lymphoma 41
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 41
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis 41
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1-Statement of the Issue and a Review of Available Resources 41
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 41
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 41
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 40
Exploration of Disease Markers under Translational Medicine Model 40
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 40
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 40
Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT 40
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 40
Consensus on molecular imaging and theranostics in prostate cancer 40
Fourier amplitude image circumferential profile analysis in the evaluation of the dipyridamole test 40
A risk management approach for imaging biomarker-driven clinical trials in oncology 40
Prone scintimammography in patients with non-palpable breast lesions 40
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 39
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 39
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 39
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 39
SENSITIVITY VERSUS SPECIFICITY IN MELANOMA IMAGING USING I-123 IODOBENZAMIDE AND IN-111 PENTETREOTIDE 39
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 39
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 39
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) 39
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 39
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 39
Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit 38
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 38
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 38
Assessment of tumor response in malignant pleural mesothelioma 38
Nuclear medicine imaging of neuroendocrine tumours 38
EANM procedure guidelines for I-131-meta-iodobenzylguanidine (I-131-mIBG) therapy 38
Feasibility of Carbidopa Premedication in Pediatric Patients: A Pilot Study 38
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 38
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data 38
Reply to comment on Pepe et al.: Somatostatin receptor SPECT 37
Cardiac and Acoustic Metastases in Relapsing Melanoma 37
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 37
Why New Journals? The Growth of the EJNMMI Family 37
Imaging of therapy response in oncology FOREWORD 37
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 37
F-18-FDG PET/CT scans for children and adolescents 37
Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide 37
LUNG UPTAKE OF TL-201 IN MYOCARDIAL STRESS IMAGING - CORRELATION WITH ECHOCARDIOGRAPHIC AND SCINTIGRAPHIC VARIABLES OF MYOCARDIAL-ISCHEMIA 37
Dementia with Lewy bodies with supranuclear gaze palsy: a matter of diagnosis 37
Totale 4403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0000 00 00 00020
2020/20213910 38514517 371235 546280 73950438380
2021/20221926 1611762417 3728 73260 16312948891
2022/20235097 752197464566 458467 23419 9634423460
Totale 10953